Filing Details
- Accession Number:
- 0001213900-20-008708
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-06 21:10:39
- Reporting Period:
- 2020-03-31
- Accepted Time:
- 2020-04-06 21:10:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1402479 | Myos Rens Technology Inc. | MYOS | Pharmaceutical Preparations (2834) | 900772394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1803073 | Joel Andrew Ponte | C/O Myos Rens Technology Inc. 45 Horsehill Road, Suite 106 Cedar Knolls NJ 07927 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-31 | 3,306 | $0.00 | 97,499 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares of common stock were awarded to the reporting person under the registrant's 2012 Equity Incentive Plan and will vest immediately.
Billionaire Hedge Funds
